Pages that link to "Q37513871"

The following pages link to Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4 (Q37513871):

Displaying 29 items.

• Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies (Q26830839) (← links)
• Overlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functions (Q27014714) (← links)
• Therapeutic cancer vaccines and combination immunotherapies involving vaccination (Q28397609) (← links)
• Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity. (Q33679779) (← links)
• IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells (Q34585798) (← links)
• Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies. (Q34649397) (← links)
• Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go. (Q34658452) (← links)
• Combined Tbet and IL12 gene therapy elicits and recruits superior antitumor immunity in vivo. (Q35802152) (← links)
• DNA is an efficient booster of dendritic cell-based vaccine (Q36256389) (← links)
• Antigen choice determines vaccine-induced generation of immunogenic versus tolerogenic dendritic cells that are marked by differential expression of pancreatic enzymes (Q36718256) (← links)
• Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic Type 1 polarization modulated by NK cells (Q37346827) (← links)
• Glycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine (Q37686631) (← links)
• Tolerogenic dendritic cells and their potential applications (Q37826217) (← links)
• Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination (Q38002844) (← links)
• NK cells: key to success of DC-based cancer vaccines? (Q38036202) (← links)
• Dendritic cells: cellular mediators for immunological tolerance (Q38114071) (← links)
• Immune system: a double-edged sword in cancer (Q38122647) (← links)
• Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host (Q38369289) (← links)
• DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties (Q40007199) (← links)
• λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine (Q41853661) (← links)
• Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010. (Q41963722) (← links)
• Lymphocyte-polarized DC1s: Effective inducers of tumor-specific CTLs (Q41993616) (← links)
• Capparis spinosa Fruit Ethanol Extracts Exert Different Effects on the Maturation of Dendritic Cells (Q47243622) (← links)
• Plant-derived polysaccharides activate dendritic cell-based anti-cancer immunity. (Q52647360) (← links)
• Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity. (Q53255338) (← links)
• The immunostimulatory activity of polysaccharides from Glycyrrhiza uralensis (Q89585797) (← links)
• Enhanced antitumor effect of cytotoxic T lymphocytes induced by dendritic cells pulsed with colorectal cancer cell lysate expressing α-Gal epitopes (Q91756406) (← links)
• IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma (Q92604163) (← links)
• Pleurotus ferulae polysaccharides improve the antitumor efficacy of therapeutic human papillomavirus dendritic cell-based vaccine (Q93070827) (← links)